Drug Screening: Core Growth Enabler in the Increasing Drug And Alcohol Usage Market, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Drug Screening Industry Market Size Be by 2025?
The size of the drug screening market has witnessed significant growth in the past few years. It is projected to increase from $8.57 billion in 2024 to $9.72 billion in 2025, with a compound annual growth rate (CAGR) of 13.3%. The expansion during the historic period can be credited to factors such as pharmaceutical drug testing, healthcare and clinical diagnostic practices, treatment of substance abuse, investment towards research and development, and the rising use of drug testing kits and instruments.

What's the Long-Term Growth Forecast for the Drug Screening Market Size Through 2029?
Expectations are high for the drug screening market to experience significant growth in the coming years, with projections estimating its value to be at $16.86 billion by 2029, showcasing a compound annual growth rate (CAGR) of 14.8%. This anticipated growth during the forecast period can be linked to factors such as the legalization of cannabis* and opioid crisis, increased sporting events, the prevalence of point-of-care and swift testing, alterations in drug policies and regulations, an uptick in workplace health and wellness programs, and the extension into international markets. Key trends projected for this forecast period encompass advancements in drug detection technology, the growth of telemedicine and remote testing, increased investment in research and development, the innovation of drug testing kits and devices, and progress in testing technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

What Are the Key Growth Drivers Fueling the Drug Screening Market Expansion?
The rise in substance abuse, specifically amongst drugs and alcohol, is projected to boost the drug screening market's progression. Substance addiction, including drugs like alcohol, marijuana, and nicotine, is a medical disorder that impacts an individual's brain function and behavior, leading to a lack of control over the use of lawful or unlawful drugs or pharmaceuticals. With the surge in drug and alcohol addiction, the probability of illness escalates, stimulating the requirement for drug screening. For example, in 2022, the prevalent issue worldwide remained to be the alcohol and drug consumption. As per the National Survey on Drug Use and Health (NSDUH), drugs were used by 13.5% of Americans who are 12 years old and above in the last month, witnessing a 3.8% per annum enhancement. Additionally, the survey reveals that illegal drugs or prescription drugs were misused by 59.277 million or 21.4% of individuals who are 12 years old and above within the previous year. The COVID-19 pandemic also inflates drug threats, with an increase in cannabis* consumption by adolescents rising up to four times in certain global regions. Consequently, the augmentation in drug and alcohol usage stimulates the drug screening market's growth during the forecasted period.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp

What Are the Key Trends Driving Drug Screening Market Growth?
Introducing novel products is becoming a prominent trend in the drug screening market. To keep up with the rapidly expanding industry demand and solidify their standing in the market, key companies in this sector are concentrating on product innovation and introductions. Moreover, the onset of COVID has led to a significant shift in drug screening practices, leading to changes in screening methods and motivating businesses to innovate and create new products. The companies' goal is to create effective new drugs that can be readily used in laboratories on a wide scale. For example, Sysmex Corporation, a healthcare company based in Japan, launched a novel product, the UF-1500 Fully Automated Urine Particle Testing Analyzer, in September 2022. This product is designed for urine sediment testing and screening. The UF-1500 carries forward the superior functionality and user-friendly features of the UF-5000 Fully Automated Urine Particle Analyzer, the flagship product of Sysmex in urine sediment testing, while making the older model more compact.

How Is the Drug Screening Market Segmented?
The drug screening market covered in this report is segmented -

1) By Products: Rapid Testing Devices, Consumables, Other Products
2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types
3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges

Subsegments:
1) By Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips
2) By Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards
3) By Other Products: Laboratory Equipment, Software Solutions, Storage and Transport Solutions

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=6369&type=smp

Which Companies Are Leading the Charge in Drug Screening Market Innovation?
Major companies operating in the drug screening market include Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

Which Regions Are Leading the Global Drug Screening Market in Revenue?
North America was the largest region in the drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6369

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.